Weinstein MH - Search Results

1

Prostate carcinoma tissue proteomics for biomarker discovery.

Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH, O'Leary MP, Richie JP, Mok SC, Liu BC. Zheng Y, et al. Among authors: weinstein mh. Cancer. 2003 Dec 15;98(12):2576-82. doi: 10.1002/cncr.11849. Cancer. 2003. PMID: 14669276 Free article.

2

Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection.

Liu BC, LaRose I, Weinstein LJ, Ahn M, Weinstein MH, Richie JP. Liu BC, et al. Among authors: weinstein mh. Cancer. 2001 Oct 1;92(7):1943-8. doi: 10.1002/1097-0142(20011001)92:7<1943::aid-cncr1713>3.0.co;2-m. Cancer. 2001. PMID: 11745269

3

Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy.

Lieberfarb ME, Schultz D, Whittington R, Malkowicz B, Tomaszewski JE, Weinstein M, Wein A, Richie JP, D'Amico AV. Lieberfarb ME, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):898-903. doi: 10.1016/s0360-3016(02)02812-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095555

4

Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

Linson PW, Lee AK, Doytchinova T, Chen MH, Weinstein MH, Richie JP, D'Amico AV. Linson PW, et al. Among authors: weinstein mh. Urology. 2002 May;59(5):704-8. doi: 10.1016/s0090-4295(01)01665-x. Urology. 2002. PMID: 11992844

5

Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland.

D'Amico AV, Weinstein M, Li X, Richie JP, Fujimoto J. D'Amico AV, et al. Urology. 2000 May;55(5):783-7. doi: 10.1016/s0090-4295(00)00475-1. Urology. 2000. PMID: 10792101 Clinical Trial.

6

Transperineal magnetic resonance image guided prostate biopsy.

D'Amico AV, Tempany CM, Cormack R, Hata N, Jinzaki M, Tuncali K, Weinstein M, Richie JP. D'Amico AV, et al. J Urol. 2000 Aug;164(2):385-7. J Urol. 2000. PMID: 10893591

7

Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.

D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, Rhude M, Rocha S, Wein A, Richie JP. D'Amico AV, et al. J Urol. 2001 Dec;166(6):2185-8. J Urol. 2001. PMID: 11696732

8

Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?

Lee AK, Doytchinova T, Chen MH, Renshaw AA, Weinstein M, Richie JP, D'Amico AV. Lee AK, et al. Among authors: weinstein m. Urol Oncol. 2003 Mar-Apr;21(2):123-7. doi: 10.1016/s1078-1439(02)00240-5. Urol Oncol. 2003. PMID: 12856640

9

The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy.

Nguyen PL, Lin DI, Lei J, Fiorentino M, Mueller E, Weinstein MH, Pagano M, Loda M. Nguyen PL, et al. Among authors: weinstein mh. Urol Oncol. 2011 May-Jun;29(3):302-8. doi: 10.1016/j.urolonc.2009.03.022. Epub 2009 May 17. Urol Oncol. 2011. PMID: 19450994 Free PMC article.

10

Angiosarcoma arising in a testicular teratoma.

Steele GS, Clancy TE, Datta MW, Weinstein M, Richie JP. Steele GS, et al. J Urol. 2000 Jun;163(6):1872-3. J Urol. 2000. PMID: 10799210 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters